Please try another search
For the three months ended 31 March 2022, MiCo BioMed Co Ltd revenues decreased 25% to W9.37B. Net loss totaled W3.9B vs. income of W1.79B. Revenues reflect Finished Goods Revenues decrease of 26% to W8.69B, Other Revenue decrease of 16% to W327.1M, Merchandise Sales decrease of 13% to W352.9M. Net loss reflects Interest Expense increase from W112.8M to W553.3M (expense), R & D Expense increase of 17% to W2.07B (expense).
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 1087.54 | 1406.04 | 1350.38 | 1523.46 |
Gross Profit | -3757.33 | -625.26 | -2643.14 | 54.63 |
Operating Income | -7696.33 | -3275.25 | -5549.89 | -3461.43 |
Net Income | -10825.68 | -5077.16 | -5096.17 | -4775.25 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 61317.99 | 44986.02 | 46075.27 | 50881.06 |
Total Liabilities | 24989.16 | 41713.8 | 37858.15 | 37683.6 |
Total Equity | 36328.83 | 3272.22 | 8217.12 | 13197.46 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -4609.59 | -2533.89 | -1831.1 | -2384.24 |
Cash From Investing Activities | -14829.74 | -3774.7 | 5208.18 | 4831.71 |
Cash From Financing Activities | 23743.73 | 3858.11 | -1135.83 | -2878.73 |
Net Change in Cash | 4215.15 | -2395.32 | 2208.8 | -353.09 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review